{"gene":"HNF4A","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1996,"finding":"HNF4A (TCF14) was identified as the MODY1 gene; it is a member of the steroid/thyroid hormone receptor superfamily and functions as an upstream transcriptional regulator of HNF-1alpha expression, establishing its position in a transcriptional hierarchy governing pancreatic beta-cell function.","method":"Genetic linkage analysis, gene identification, positional cloning","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — landmark positional cloning study replicated across multiple labs; HNF4A's role as upstream regulator of HNF1A is a foundational finding independently confirmed","pmids":["8945471"],"is_preprint":false},{"year":1997,"finding":"The MODY1 nonsense mutation Q268X causes loss of HNF4A transcriptional transactivation activity and abolishes dimerization and DNA binding. Loss of HNF4A function in embryonic stem cells-derived visceral endoderm reduces expression of glucose transporter 2, aldolase B, glyceraldehyde-3-phosphate dehydrogenase, liver pyruvate kinase, and fatty acid binding proteins, demonstrating HNF4A directly regulates glucose transport and glycolysis genes.","method":"Functional assays in mutant protein; embryonic stem cell visceral endoderm differentiation system; gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (mutant protein functional assay, genetic loss-of-function in ES cells, gene expression profiling); replicated conceptually by subsequent studies","pmids":["9371825"],"is_preprint":false},{"year":1998,"finding":"The MODY1 Q268X mutant protein cannot bind DNA alone or as a dimer with wild-type HNF4A in EMSA, yet retains the ability to dimerize with wild-type HNF4A in solution (co-immunoprecipitation). Despite dimerization, it does not exert dominant-negative transcriptional effects in vivo; instead it shows striking cytoplasmic/insoluble localization (extractable only with SDS), suggesting MODY1 phenotype results from loss of functional nuclear HNF4A, particularly pronounced in pancreas where HNF4A levels are low.","method":"EMSA, co-immunoprecipitation, transient transfection, subcellular fractionation/immunofluorescence","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal methods (EMSA, co-IP, transfection, localization) in single study; mechanistically precise","pmids":["9604881"],"is_preprint":false},{"year":1998,"finding":"GATA6 lies upstream of HNF4A in a transcriptional cascade required for visceral endoderm differentiation: GATA6-deficient embryos lack HNF4 gene expression, and forced GATA6 expression activates the HNF4 promoter in non-endodermal cells.","method":"Gene targeting (GATA6 knockout ES cells and mice), promoter activation assay, in situ hybridization","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function plus gain-of-function promoter assay; replicated in ES cells and whole-animal knockout","pmids":["9832509"],"is_preprint":false},{"year":1999,"finding":"The MODY1 missense mutation HNF4(E276Q) is a loss-of-function mutation: it cannot bind HNF-4 consensus DNA sites or activate transcription. A truncated 40-kDa C-terminal product of E276Q can co-immunoprecipitate with wild-type HNF4A and exerts weak dominant-negative activity in non-beta-cell types. Glutamic acid 276 in helix 8 of the LBD is identified as critical for DNA binding, transactivation, and protein stability. HNF4(R127W) and HNF4(V255M) show transactivation indistinguishable from wild-type.","method":"Transcriptional activation assay, EMSA, co-immunoprecipitation, Western blot, cell-type-specific transfection","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal biochemical methods (EMSA, co-IP, transactivation, Western) in single rigorous study","pmids":["10389854"],"is_preprint":false},{"year":1999,"finding":"HNF4 regulates apolipoprotein CIII (apoCIII) gene transcription through a DR1 binding site at position -746 in the apoCIII promoter. MAP kinase signaling modulates apoCIII expression partly via changes in HNF4 mRNA and protein levels; repression of MAP kinase increases HNF4 expression and apoCIII transcription.","method":"Transient transfection/reporter assay in HepG2, EMSA, promoter deletion mapping, pharmacological MAP kinase inhibition","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus reporter assay, single lab; MAP kinase regulation of HNF4 expression is a secondary inference","pmids":["10551874"],"is_preprint":false},{"year":2000,"finding":"HNF4 and COUP-TFII synergistically activate transcription of the CYP7A1 (cholesterol 7alpha-hydroxylase) promoter. HNF4 binds a DR1 element at nt -146 to -134 of the CYP7A1 promoter, and synergy with COUP-TFII involves protein-protein interactions facilitated by juxtaposed binding elements rather than requiring independent COUP-TFII DNA binding.","method":"EMSA with rat liver nuclear extracts, cotransfection assays in HepG2, site-directed mutagenesis of promoter elements","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA, cotransfection, mutagenesis in single lab; protein-protein interaction inference based on functional data","pmids":["10627496"],"is_preprint":false},{"year":2000,"finding":"HNF4A haploinsufficiency (not hyperglycemia) is the primary cause of reduced serum levels of apolipoprotein AII, apoCIII, lipoprotein(a), and triglycerides in MODY1 mutation carriers, demonstrating HNF4A is a required transcriptional regulator of these hepatic secretory proteins in vivo.","method":"Serum protein measurement in genotyped MODY1 pedigree members (diabetic HNF4+/-, nondiabetic HNF4+/-, normal HNF4+/+); genetic haploinsufficiency analysis","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — carefully controlled human genetics study with multiple protein measurements; single family pedigree","pmids":["10905494"],"is_preprint":false},{"year":2000,"finding":"The R127W-HNF4A mutation reduces DNA binding ability and transcriptional activation of HNF-1alpha and L-type pyruvate kinase (PKL) genes; nuclear import and functional synergy with coactivator CBP are normal, confirming R127W is a loss-of-function mutation.","method":"Transcriptional activation assay, EMSA, co-immunoprecipitation with CBP, immunofluorescence for nuclear localization","journal":"Diabetologia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays, single lab","pmids":["10819248"],"is_preprint":false},{"year":2004,"finding":"HNF4 stimulates expression of the precore RNA and core RNA from the hepatitis B virus (HBV) core promoter by binding to a nuclear receptor binding site; this effect is more prominent on the wild-type than on the A1762T/G1764A double-mutant core promoter. The X protein does not affect HNF4 activity on the core promoter.","method":"Reporter assay in Huh7 hepatoma cells, cotransfection, HBV genomic constructs with/without X protein","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assays with multiple constructs, single lab","pmids":["15194767"],"is_preprint":false},{"year":2005,"finding":"HNF4A is required in pancreatic beta cells for regulation of the ATP-dependent potassium channel pathway of insulin secretion; conditional beta-cell knockout mice show hyperinsulinemia but impaired glucose tolerance, with ~60% reduction in Kir6.2 (KCNJ11) expression. Cotransfection assays demonstrate Kir6.2 is a direct transcriptional target of HNF4A.","method":"Cre-loxP conditional knockout, islet perifusion, calcium imaging, cotransfection assay, quantitative gene expression","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional knockout with defined physiological phenotype plus in vitro transcriptional target validation; multiple orthogonal methods","pmids":["15761495"],"is_preprint":false},{"year":2008,"finding":"HNF4A directly activates the COUP-TFII (NR2F2) promoter via a DR-1 binding site in pancreatic beta cells (demonstrated by ChIP and reporter/mutagenesis), and COUP-TFII in turn positively regulates HNF4A mRNA levels, forming a positive feedback loop. COUP-TFII also autorepreses its own promoter via the same DR-1 site.","method":"ChIP, promoter reporter assay, site-directed mutagenesis, dominant-negative suppression, siRNA knockdown, adenoviral overexpression in 832/13 INS-1 cells and mouse islets","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP plus mutagenesis plus gain/loss-of-function in both cell line and primary islets; multiple orthogonal methods","pmids":["18474611"],"is_preprint":false},{"year":2009,"finding":"HNF4A binds to and regulates the hepatocyte-specific expression of the ACAT2 (cholesterol esterification enzyme) promoter, as confirmed by ChIP assay in human liver and site-directed mutagenesis of an HNF4 binding site; HNF4A can act directly or indirectly via HNF1alpha. MODY1 patients have lower VLDL and LDL esterified cholesterol consistent with reduced ACAT2 activity.","method":"ChIP assay in human liver, mutagenesis, cotransfection in HuH7 cells, lipoprotein profiling in MODY1 patients","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP in human tissue plus mutagenesis plus human clinical validation; multiple orthogonal methods","pmids":["19478207"],"is_preprint":false},{"year":2009,"finding":"Genome-wide ChIP-seq reveals HNF4A binds ~18,783 peaks in hepatic cells, predominantly at non-promoter positions (90% distal elements). HNF4A co-occupies sites with FOXA2, and an HNF4A–GABP interaction at transcription start sites was identified and verified by co-immunoprecipitation.","method":"ChIP-seq, co-immunoprecipitation","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus co-IP, single lab","pmids":["19822575"],"is_preprint":false},{"year":2014,"finding":"In mouse liver development, HNF4A binding to enhancers is differentiation-dependent, with embryonic enhancers responsive to TEAD2/YAP1 (Hippo signaling). Hippo pathway activity influences which temporal enhancers HNF4A and FOXA2 occupy during hepatocyte differentiation.","method":"ChIP-seq in vivo across developmental stages, chromatin remodeling analysis, gene expression profiling","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq in vivo, single lab; functional validation of Hippo-HNF4A link is indirect","pmids":["25263553"],"is_preprint":false},{"year":2016,"finding":"Drosophila HNF4 (dHNF4) is required in the fat body and insulin-producing cells for a developmental switch toward oxidative phosphorylation and glucose-stimulated insulin secretion at the adult transition. Loss of dHNF4 causes adult-onset hyperglycemia, glucose intolerance, and impaired GSIS, linked to reduced mitochondrial function and decreased expression of Hex-C (glucokinase homolog).","method":"Drosophila genetic loss-of-function, metabolic assays, glucose tolerance test, insulin secretion assay, gene expression","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo animal model with defined genetic loss-of-function and multiple physiological phenotypic readouts; well-controlled Drosophila ortholog study","pmids":["27185732"],"is_preprint":false},{"year":2017,"finding":"DDX3 RNA helicase interacts with HNF4A and co-activates HNF4A-mediated transactivation of the MTP (microsomal triglyceride transfer protein) promoter. DDX3 enhances HNF4A acetylation via CBP/p300 interaction, increases HNF4A promoter binding affinity, and competes with the repressor SHP for HNF4A binding, disrupting the inactive HNF4A/SHP heterodimer and promoting active HNF4A homodimer formation.","method":"Co-immunoprecipitation, luciferase reporter assay, ChIP, ATPase activity assay, siRNA knockdown","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, ChIP, reporter assay with mutagenesis approach; single lab, multiple methods","pmids":["28128295"],"is_preprint":false},{"year":2017,"finding":"TET-catalyzed 5-hydroxymethylation (5hmC) at the HNF4A P1 promoter precedes expression of P1 promoter-derived HNF4A isoforms during hepatocyte differentiation. TET dioxygenases and the pioneer factor FOXA2 are required for 5hmC at P1 and subsequent P1-driven HNF4A expression; FOXA2 is necessary for TET1 binding to the P1 locus.","method":"5hmC/5mC mapping, TET inhibition, FOXA2 knockdown, in vitro hepatocyte differentiation model","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epigenetic mapping plus functional knockdown experiments in differentiation model; single lab","pmids":["28648900"],"is_preprint":false},{"year":2018,"finding":"HNF4A strongly transrepresses CLOCK:BMAL1 heterodimer transcriptional activity, defining a negative feedback loop in the hepatic circadian clock. Genome-wide ChIP-seq shows HNF4A binding at CLOCK:BMAL1 co-occupied metabolic gene loci is rhythmic in mouse liver. HNF4A maintains cell-autonomous circadian oscillations in a tissue-specific manner in liver and colon cells.","method":"Transcriptional reporter assay (transrepression), ChIP-seq, circadian oscillation assay (luciferase reporter), cell-autonomous oscillation measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus functional transrepression assay plus cell-autonomous oscillation experiments; multiple orthogonal methods, single lab","pmids":["30530698"],"is_preprint":false},{"year":2018,"finding":"Kidney-specific deletion of Hnf4a in mice causes Fanconi renotubular syndrome-like phenotype (polyuria, polydipsia, glycosuria, phosphaturia) with failure of proximal tubule differentiation and loss of proximal tubule-specific gene expression; Hnf4a is required for differentiated but not presumptive proximal tubule formation.","method":"Conditional kidney-specific Hnf4a knockout mice, histology, gene expression, physiological phenotyping","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional knockout with multiple defined phenotypic readouts; well-controlled study","pmids":["30046000"],"is_preprint":false},{"year":2019,"finding":"HNF4A and SMAD4 form a reinforcing feed-forward loop in the intestine: they activate each other's expression and co-bind regulatory elements of differentiation genes. Double knockout of HNF4A and its paralog HNF4G abolishes enterocyte differentiation; HNF4 activates enhancer chromatin and upregulates the majority of transcripts enriched in differentiated intestinal epithelium.","method":"Double conditional knockout (HNF4A/HNF4G), ChIP-seq, ATAC-seq, RNA-seq, gene expression profiling","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo double knockout plus genome-wide ChIP-seq and chromatin accessibility; multiple orthogonal methods","pmids":["30988513"],"is_preprint":false},{"year":2019,"finding":"HNF4A and HNF4G are required for intestinal stem cell renewal via direct transcriptional activation of fatty acid oxidation (FAO) genes including Acsl5, Acsf2, Slc27a2, Fabp2, and Hadh. Loss of both paralogs reduces FAO activity, TCA cycle metabolites, and Lgr5+ stem cell markers; restoration of acetyl-CoA via acetate or dichloroacetate rescues stem cells.","method":"Double conditional knockout (Hnf4a/Hnf4g), ChIP-seq, metabolic assays (FAO activity, TCA metabolites), isotope tracing, organoid rescue experiments","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo double knockout plus ChIP-seq plus metabolic tracing plus organoid rescue; multiple orthogonal methods","pmids":["31759926"],"is_preprint":false},{"year":2019,"finding":"The HNF4A p.Ile271fs MODY1 mutant does not undergo complete nonsense-mediated decay and does not exert dominant negativity; loss of function is due to impaired transcriptional activation of target genes. MODY1-iPSC-derived hepatopancreatic progenitors with reduced HNF4A show downregulation of foregut genes and upregulation of hindgut HOX genes.","method":"Patient-derived iPSC differentiation, gene expression profiling, HNF4A localization by immunofluorescence","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — iPSC model with gene expression profiling; single lab, mechanistic interpretation is partly inferential","pmids":["31195238"],"is_preprint":false},{"year":2019,"finding":"The FRTS-associated HNF4A R85W mutation (in the DNA-binding domain) causes nuclear depletion and cytosolic aggregation of wild-type dHNF4 protein in Drosophila nephrocytes. Nuclear depletion leads to mitochondrial defects and lipid droplet accumulation; cytosolic aggregates trigger ER expansion, autophagy, and cell death. Blocking serine phosphorylation in the DBD prevents nuclear export and rescues the cytosolic aggregation phenotype.","method":"Drosophila nephrocyte expression system, confocal microscopy, electron microscopy, phosphorylation site mutagenesis, genetic rescue","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic mutagenesis rescue plus in vivo cellular phenotyping with multiple readouts; well-controlled Drosophila ortholog study","pmids":["31875549"],"is_preprint":false},{"year":2020,"finding":"Mir214-3p suppresses Ulk1 expression by direct binding to the 3' UTR of Ulk1, while HNF4A (Hnf4a) directly activates Ulk1 transcription (demonstrated by ChIP). In nonalcoholic fatty liver, increased Mir214-3p and decreased Hnf4a reduce autophagic activity; silencing Mir214-3p increases Ulk1 and autophagic flux, but not under Ulk1 suppression, placing HNF4A upstream of ULK1-mediated autophagy.","method":"ChIP (HNF4A binding to Ulk1 promoter), luciferase 3'UTR assay, LNA-mediated miRNA silencing, autophagy flux assays in mouse liver","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus functional epistasis in vivo; single lab","pmids":["33078654"],"is_preprint":false},{"year":2021,"finding":"Therapeutic delivery of HNF4A mRNA via lipid nanoparticles to mouse liver attenuates fibrosis in four independent models. Paraoxonase 1 (PON1) was identified as a direct HNF4A transcriptional target by ChIP; PON1 contributes to HNF4A-mediated anti-fibrotic effect via modulation of liver macrophages and hepatic stellate cells.","method":"LNP-mediated mRNA delivery in vivo, ChIP, microarray/scRNA-seq, primary cell experiments, human liver bud model","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-validated direct target plus in vivo functional rescue in multiple independent models plus single-cell mechanistic dissection","pmids":["34453962"],"is_preprint":false},{"year":2021,"finding":"HNF4 transcription factors are required for chromatin looping between enhancers and promoters at target genes in the intestinal epithelium. HNF4 depletion disrupts local enhancer-promoter chromatin interactions, histone modifications, and target gene expression; despite dynamic gene regulation during differentiation, enhancer-promoter loops are relatively stable.","method":"H3K4me3 HiChIP-seq, ATAC-seq, ChIP-seq, conditional HNF4 knockout","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — HiChIP-seq plus ChIP-seq plus genetic loss-of-function; multiple orthogonal genome-wide methods","pmids":["33503426"],"is_preprint":false},{"year":2021,"finding":"HNF4 (HNF4A and HNF4G) drives a conserved brush border gene program in intestine, kidney, and yolk sac by directly binding and activating brush border genes. HNF4 loss results in impaired chromatin looping between enhancers and promoters at brush border gene loci and enhanced looping at stress fiber gene loci.","method":"Conditional knockout (intestine, kidney, yolk sac), ChIP-seq, H3K4me3 HiChIP-seq, RNA-seq, transport assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus HiChIP plus genetic loss-of-function across multiple organs; multiple orthogonal methods","pmids":["34001900"],"is_preprint":false},{"year":2022,"finding":"HNF4A defines liver-specific glucocorticoid receptor (GR) action by acting as a lineage-determining factor: the HNF4A motif lies adjacent to glucocorticoid response elements at GR binding sites in open chromatin. In Hnf4a-null liver, the GR cistrome is remodeled—loss of GR recruitment occurs at weak GRE sites with HNF4A-marked chromatin, while GR binding is gained at strong GRE motifs normally restricted to non-liver tissues.","method":"ChIP-seq (GR, HNF4A), ATAC-seq in Hnf4a-null liver, transcriptional response analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq plus ATAC-seq in conditional knockout; multiple orthogonal methods clearly establishing mechanism","pmids":["35443180"],"is_preprint":false},{"year":2022,"finding":"HNF4A directly regulates the glucagon receptor (Gcgr) gene in mouse liver (confirmed by ChIP); liver-specific Hnf4a knockout mice show markedly reduced Gcgr expression, glucagon resistance, alpha-cell hyperplasia, and dramatically elevated glucagon levels, revealing a role for HNF4A in controlling the liver-alpha-cell axis and blood glucose homeostasis.","method":"Liver-specific conditional Hnf4a knockout (Alb-Cre), ChIP assay, glucagon challenge test, metabolic phenotyping, gene expression","journal":"Metabolism: clinical and experimental","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-validated direct target plus in vivo conditional knockout with well-defined physiological phenotype","pmids":["36464036"],"is_preprint":false},{"year":2022,"finding":"HNF4A in intestinal epithelial cells directly regulates expression of immune signaling molecules Btnl1, Btnl6, H2-T3, and Clec2e that control epithelial-intraepithelial lymphocyte (IEL) crosstalk, selectively expanding TCRγδ+ and TCRαβ+CD8αα+ natural IELs; in the small intestine HNF4A cooperates with HNF4G for this function. The HNF4A-BTNL regulatory axis is conserved in human IECs.","method":"IEC-specific conditional knockout, ChIP, gene expression, flow cytometry of IEL populations","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional knockout plus ChIP demonstrating direct regulation; functional immune phenotype measured; conservation in human IECs","pmids":["35792863"],"is_preprint":false},{"year":2023,"finding":"HNF4A binds and directly regulates known targets (ACY3, HAAO, HNF1A, MAP3K11) and previously unidentified loci (ABCD3, CDKN2AIP, USH1C, VIL1) in a tissue-dependent manner in pancreatic beta cells and hepatocytes. The T2D-associated HNF4A variant rs1800961 (unlike the loss-of-function MODY1 variant I271fs) activates AKAP1, GAD2, and HOPX expression, potentially through altered DNA-binding affinity.","method":"ChIP-seq in pancreatic and hepatic cells, functional validation of selected targets, comparison of MODY1 vs T2D variants","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq with functional follow-up across cell types; multiple orthogonal approaches in single rigorous study","pmids":["38909044"],"is_preprint":false},{"year":2023,"finding":"HNF4A directly regulates its target genes in human proximal tubules (validated by CUT&RUN sequencing showing binding at promoters and enhancers of downregulated genes). HNF4A loss (not HNF4G) in human kidney organoids impairs expression of transport-related, endocytosis-related, and brush border genes and disorganizes apical brush border structure. CRISPRa-mediated induction of HNF4A or HNF4G drives increased expression of selected target genes.","method":"HNF4A/HNF4G knockout iPSC-derived kidney organoids, CUT&RUN sequencing, CRISPRa, RNA-seq, electron microscopy","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 / Strong — human organoid KO plus CUT&RUN genome-wide binding plus CRISPRa gain-of-function; multiple orthogonal methods","pmids":["37488681"],"is_preprint":false},{"year":2024,"finding":"HNF4A binds to and represses acute-phase response genes under basal hepatic conditions. During inflammation, loss of HNF4A function is required for derepression of acute-phase genes; overexpression of HNF4A in liver organoids retains chromatin at regulatory regions of acute-phase genes inaccessible to transcription, potently impairing the acute-phase response while maintaining hepatocyte functionality.","method":"Pre-clinical liver organoid model, HNF4A overexpression, chromatin accessibility assay, transcriptome profiling","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — organoid gain-of-function plus chromatin accessibility; single lab, liver organoid model","pmids":["38755249"],"is_preprint":false},{"year":2016,"finding":"In the colonic epithelium, HNF4A cooperates with TCF7L2 in a cascade that upregulates Claudin-23 expression during differentiation, as confirmed by ChIP and Hnf4a conditional knockout mice (which fail to induce Cldn23).","method":"ChIP, microarray/gene expression, in vitro cotransfection, Hnf4a conditional knockout mice","journal":"Tissue barriers","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus in vivo conditional KO confirmation; single lab, limited to one target gene","pmids":["27583195"],"is_preprint":false},{"year":2023,"finding":"In medullary thymic epithelial cells (mTECs), HNF4α and HNF4γ activate mimetic-cell enhancers to recapitulate entero-hepato gene expression programs, with HNF4γ providing primary contribution. Loss of both Hnf4 paralogs ablates entero-hepato mTECs, impairs enhancer activation and CTCF redistribution, but does not affect Polycomb repression or promoter-proximal histone marks.","method":"Conditional Hnf4α/γ knockout in TECs, scRNA-seq, ATAC-seq, ChIP, CTCF binding analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional knockout plus scRNA-seq plus ATAC-seq plus ChIP; multiple orthogonal methods","pmids":["37399024"],"is_preprint":false}],"current_model":"HNF4A is a nuclear receptor transcription factor that functions as an obligate homodimer binding DR1 elements to activate a broad transcriptional program in liver, intestine, kidney, and pancreatic beta cells; it acts as an upstream activator of HNF1A, directly transactivates genes governing glucose transport/glycolysis (GLUT2, aldolase B, GAPDH, pyruvate kinase), fatty acid oxidation, lipoprotein metabolism (apoCIII, ACAT2, MTP), the glucagon receptor, and the ATP-sensitive K+ channel subunit Kir6.2 in beta cells, while also transrepressing CLOCK:BMAL1 circadian activity and acute-phase response genes; its activity is modulated by post-translational modifications (acetylation via CBP/p300 enhanced by DDX3, serine phosphorylation in the DBD controlling nuclear export), epigenetic control of promoter choice (TET-mediated 5hmC at P1 upstream of FOXA2), co-regulatory interactions with COUP-TFII (mutual positive feedback), SMAD4 (feed-forward loop in intestinal differentiation), and GABP; loss-of-function MODY1 mutations abolish DNA binding and transactivation, causing beta-cell dysfunction primarily through haploinsufficiency, while a specific DBD mutation (R85W) additionally triggers cytoplasmic aggregation and Fanconi renal tubular syndrome through a non-genomic mechanism."},"narrative":{"mechanistic_narrative":"HNF4A is a nuclear receptor transcription factor that sits at the apex of a tissue-restricted regulatory hierarchy, controlling differentiated cell identity and metabolic gene programs in liver, intestine, kidney, and pancreatic beta cells [PMID:8945471, PMID:9371825, PMID:30988513]. It binds DR1 elements as a dimer and is positioned within a transcriptional cascade: GATA6 acts upstream to activate HNF4 in visceral endoderm, while HNF4A in turn drives HNF1A expression [PMID:9832509, PMID:8945471]. Genome-wide, HNF4A occupies predominantly distal enhancers, co-occupying chromatin with the pioneer factor FOXA2, and it is required to establish enhancer–promoter chromatin loops and accessible chromatin at its target loci [PMID:19822575, PMID:33503426, PMID:30988513]. Through this enhancer-organizing role it directly activates broad metabolic and differentiation programs — glucose-handling and glycolytic genes (GLUT2, aldolase B, GAPDH, pyruvate kinase) [PMID:9371825], hepatic lipoprotein and cholesterol genes including apoCIII, ACAT2, CYP7A1, and MTP [PMID:10551874, PMID:19478207, PMID:10627496, PMID:28128295], the beta-cell ATP-sensitive K+ channel subunit Kir6.2 driving insulin secretion [PMID:15761495], the hepatic glucagon receptor governing the liver–alpha-cell axis [PMID:36464036], and fatty acid oxidation genes that sustain intestinal stem cell renewal [PMID:31759926]. HNF4A also acts as a lineage-determining factor that shapes glucocorticoid receptor binding in liver and as a transcriptional repressor of CLOCK:BMAL1 circadian activity and of hepatic acute-phase response genes [PMID:35443180, PMID:30530698, PMID:38755249]. Its activity is reinforced by feedback and feed-forward loops with COUP-TFII (NR2F2) in beta cells and with SMAD4 in intestine, and is tuned by co-activators including DDX3, which enhances CBP/p300-mediated acetylation and displaces the SHP repressor to favor the active homodimer [PMID:18474611, PMID:30988513, PMID:28128295]. Loss-of-function mutations in HNF4A cause MODY1 maturity-onset diabetes primarily through haploinsufficiency, with mutant proteins abolishing DNA binding and transactivation without exerting dominant-negative effects [PMID:8945471, PMID:9371825, PMID:10389854, PMID:31195238]; a DNA-binding-domain mutation (R85W) additionally produces a Fanconi renotubular syndrome phenotype via serine-phosphorylation-driven nuclear export and cytosolic aggregation [PMID:31875549, PMID:30046000].","teleology":[{"year":1996,"claim":"Established HNF4A's identity and its place in a transcriptional hierarchy, answering which gene underlies MODY1 and how it connects to beta-cell function.","evidence":"Positional cloning and genetic linkage in MODY1 pedigrees identifying HNF4A as an upstream regulator of HNF1A","pmids":["8945471"],"confidence":"High","gaps":["Direct beta-cell target genes not yet defined","Mechanism of upstream HNF1A regulation not resolved at the binding-site level"]},{"year":1997,"claim":"Connected MODY1 loss-of-function to specific metabolic genes, showing HNF4A directly drives glucose transport and glycolytic gene expression.","evidence":"Functional assay of the Q268X mutant plus loss-of-function in ES-cell-derived visceral endoderm with gene expression profiling","pmids":["9371825"],"confidence":"High","gaps":["Direct vs indirect regulation of individual targets not separated","Pancreatic relevance inferred from endoderm model"]},{"year":1998,"claim":"Resolved whether MODY1 acts by dominant-negative interference or loss of function, and identified an aberrant subcellular fate of mutant protein.","evidence":"EMSA, co-immunoprecipitation, transfection, and subcellular fractionation of Q268X mutant","pmids":["9604881"],"confidence":"High","gaps":["Cause of cytoplasmic/insoluble localization not mechanistically defined","Single mutant studied"]},{"year":1998,"claim":"Placed HNF4A within a developmental cascade by identifying GATA6 as its upstream activator in visceral endoderm.","evidence":"GATA6 knockout ES cells/mice plus HNF4 promoter activation assay","pmids":["9832509"],"confidence":"High","gaps":["Direct vs indirect promoter activation by GATA6 not fully resolved","Restricted to endoderm context"]},{"year":1999,"claim":"Mapped a critical LBD residue (E276) for DNA binding, transactivation, and stability, and distinguished true loss-of-function from neutral MODY variants.","evidence":"Transactivation, EMSA, co-IP, and Western analysis of E276Q, R127W, and V255M mutants in multiple cell types","pmids":["10389854"],"confidence":"High","gaps":["Weak dominant-negative effect of truncated product not tested in beta cells in vivo","Structural basis of E276 role not directly determined"]},{"year":1999,"claim":"Demonstrated direct DR1-mediated regulation of a hepatic lipoprotein gene and a signaling input modulating HNF4A levels.","evidence":"Reporter assays, EMSA, promoter mapping, and MAP kinase inhibition in HepG2 for apoCIII","pmids":["10551874"],"confidence":"Medium","gaps":["MAP kinase control of HNF4A expression is a secondary inference","Single cell line"]},{"year":2000,"claim":"Showed HNF4A synergizes with COUP-TFII at a lipid-metabolism promoter through protein–protein interaction rather than independent COUP-TFII DNA binding.","evidence":"EMSA, cotransfection, and promoter mutagenesis for CYP7A1 in HepG2","pmids":["10627496"],"confidence":"Medium","gaps":["Direct physical interaction inferred from functional data, not co-IP","Single lab"]},{"year":2000,"claim":"Established that the in vivo MODY1 lipid phenotype arises from haploinsufficiency rather than secondary hyperglycemia.","evidence":"Serum protein measurement across genotyped MODY1 pedigree members","pmids":["10905494"],"confidence":"Medium","gaps":["Single family pedigree","Direct transcriptional regulation of each serum protein not all demonstrated"]},{"year":2000,"claim":"Confirmed R127W as loss-of-function affecting DNA binding while preserving nuclear import and CBP synergy, refining genotype–mechanism mapping.","evidence":"Transactivation, EMSA, co-IP with CBP, and immunofluorescence for HNF1A and PKL targets","pmids":["10819248"],"confidence":"Medium","gaps":["Single lab","In vivo beta-cell consequence not measured"]},{"year":2005,"claim":"Linked HNF4A directly to the insulin secretion machinery by identifying Kir6.2 as a target underlying the beta-cell secretory phenotype.","evidence":"Beta-cell conditional knockout with perifusion/calcium imaging plus cotransfection target validation","pmids":["15761495"],"confidence":"High","gaps":["Full set of beta-cell targets explaining hyperinsulinemia not enumerated","Direct binding by ChIP not shown in this study"]},{"year":2008,"claim":"Defined a positive feedback circuit between HNF4A and COUP-TFII in beta cells, explaining transcriptional network stabilization.","evidence":"ChIP, reporter mutagenesis, siRNA, and adenoviral overexpression in INS-1 cells and islets","pmids":["18474611"],"confidence":"High","gaps":["Mechanism of COUP-TFII-mediated HNF4A upregulation not resolved","Tissue-specificity of loop not tested"]},{"year":2009,"claim":"Provided the first genome-wide view showing HNF4A acts predominantly at distal enhancers and co-occupies sites with FOXA2 and GABP.","evidence":"ChIP-seq in hepatic cells plus co-immunoprecipitation","pmids":["19822575"],"confidence":"Medium","gaps":["Functional consequence of GABP interaction not dissected","Single lab"]},{"year":2009,"claim":"Established HNF4A as a direct hepatic regulator of cholesterol esterification via ACAT2, with human clinical correlation.","evidence":"ChIP in human liver, promoter mutagenesis, cotransfection, and MODY1 lipoprotein profiling","pmids":["19478207"],"confidence":"High","gaps":["Relative contribution of direct vs HNF1A-mediated regulation unresolved"]},{"year":2014,"claim":"Showed HNF4A enhancer selection is developmentally dynamic and integrates Hippo (TEAD2/YAP1) signaling during hepatocyte differentiation.","evidence":"Developmental-stage ChIP-seq with chromatin and expression profiling in mouse liver","pmids":["25263553"],"confidence":"Medium","gaps":["Functional Hippo–HNF4A link is indirect","Mechanism directing temporal enhancer choice unresolved"]},{"year":2016,"claim":"Demonstrated through the Drosophila ortholog that HNF4 drives a developmental metabolic switch toward oxidative phosphorylation and glucose-stimulated insulin secretion.","evidence":"Drosophila genetic loss-of-function with metabolic, glucose tolerance, and insulin secretion assays","pmids":["27185732"],"confidence":"High","gaps":["Conservation of specific target genes in mammals not all established here"]},{"year":2016,"claim":"Identified cooperation with TCF7L2 to control an epithelial barrier gene during colonic differentiation.","evidence":"ChIP, expression profiling, cotransfection, and Hnf4a conditional knockout for Cldn23","pmids":["27583195"],"confidence":"Medium","gaps":["Limited to a single target gene","Direct HNF4A–TCF7L2 interaction not shown"]},{"year":2017,"claim":"Revealed post-translational control of HNF4A: DDX3 promotes CBP/p300-mediated acetylation and shifts the equilibrium from the inactive SHP heterodimer to the active homodimer.","evidence":"Co-IP, ChIP, ATPase assay, and reporter/siRNA experiments on MTP regulation","pmids":["28128295"],"confidence":"Medium","gaps":["Acetylation site mapping not defined","Single lab"]},{"year":2017,"claim":"Defined epigenetic control of HNF4A promoter choice, showing FOXA2-dependent TET activity deposits 5hmC at the P1 promoter to enable P1 isoform expression.","evidence":"5hmC/5mC mapping, TET inhibition, and FOXA2 knockdown in a hepatocyte differentiation model","pmids":["28648900"],"confidence":"Medium","gaps":["Functional difference between P1 and P2 isoforms not tested here","Single differentiation system"]},{"year":2018,"claim":"Identified HNF4A as a transrepressor of CLOCK:BMAL1, integrating it into the hepatic circadian clock with rhythmic genomic binding.","evidence":"Transrepression reporter, ChIP-seq, and cell-autonomous oscillation assays in liver and colon cells","pmids":["30530698"],"confidence":"High","gaps":["Mechanism of transrepression at the molecular level not resolved","In vivo circadian phenotype of HNF4A loss not measured here"]},{"year":2018,"claim":"Established a non-diabetic, kidney-specific requirement for HNF4A in proximal tubule differentiation, modeling Fanconi renotubular syndrome.","evidence":"Kidney-specific conditional knockout with histology, expression, and physiological phenotyping","pmids":["30046000"],"confidence":"High","gaps":["Direct proximal-tubule target genes not all defined here","Distinction from presumptive tubule formation mechanism unresolved"]},{"year":2019,"claim":"Defined a reinforcing HNF4A–SMAD4 feed-forward loop and showed HNF4A/HNF4G redundancy is essential for enterocyte differentiation and enhancer activation.","evidence":"Double conditional knockout with ChIP-seq, ATAC-seq, and RNA-seq","pmids":["30988513"],"confidence":"High","gaps":["Direct HNF4A–SMAD4 physical interaction not shown","Paralog-specific contributions not separated"]},{"year":2019,"claim":"Linked HNF4 to intestinal stem cell renewal through direct activation of fatty acid oxidation genes feeding the TCA cycle.","evidence":"Double conditional knockout with ChIP-seq, metabolic tracing, and organoid acetyl-CoA rescue","pmids":["31759926"],"confidence":"High","gaps":["Mechanism connecting acetyl-CoA to stem cell maintenance not fully resolved"]},{"year":2019,"claim":"Showed an additional MODY1 frameshift mutant acts by impaired transactivation without dominant negativity and perturbs foregut/hindgut identity.","evidence":"Patient-derived iPSC hepatopancreatic differentiation with expression profiling and localization","pmids":["31195238"],"confidence":"Medium","gaps":["Mechanistic interpretation partly inferential","Single lab"]},{"year":2019,"claim":"Explained the FRTS R85W phenotype as a non-genomic mechanism: serine-phosphorylation-driven nuclear export causing cytosolic aggregation and cell stress.","evidence":"Drosophila nephrocyte expression with confocal/EM imaging, phosphosite mutagenesis, and genetic rescue","pmids":["31875549"],"confidence":"High","gaps":["Identity of the responsible kinase not determined","Conservation in human kidney cells not tested here"]},{"year":2020,"claim":"Placed HNF4A upstream of ULK1-mediated autophagy in fatty liver via direct transcriptional activation, with miR-214-3p as an opposing regulator.","evidence":"ChIP, luciferase 3'UTR assay, LNA miRNA silencing, and autophagy flux assays in mouse liver","pmids":["33078654"],"confidence":"Medium","gaps":["Single lab","Direct binding site on Ulk1 promoter not mapped"]},{"year":2021,"claim":"Demonstrated therapeutic anti-fibrotic potential of restoring HNF4A and identified PON1 as a direct mediator.","evidence":"LNP HNF4A mRNA delivery in four fibrosis models, ChIP, and single-cell mechanistic dissection","pmids":["34453962"],"confidence":"High","gaps":["Full anti-fibrotic target set beyond PON1 not defined"]},{"year":2021,"claim":"Established HNF4 as an organizer of enhancer–promoter chromatin looping required for target gene expression in the intestine.","evidence":"H3K4me3 HiChIP-seq, ATAC-seq, ChIP-seq with conditional HNF4 knockout","pmids":["33503426"],"confidence":"High","gaps":["Whether HNF4 directly mediates loop formation or acts via cofactors unresolved"]},{"year":2021,"claim":"Generalized HNF4's role to a conserved brush-border gene program across intestine, kidney, and yolk sac with loop reorganization.","evidence":"Multi-organ conditional knockout with ChIP-seq, HiChIP, RNA-seq, and transport assays","pmids":["34001900"],"confidence":"High","gaps":["Mechanism of gained looping at stress fiber loci not resolved"]},{"year":2022,"claim":"Defined HNF4A as a lineage-determining factor that shapes the liver glucocorticoid receptor cistrome.","evidence":"GR and HNF4A ChIP-seq plus ATAC-seq in Hnf4a-null liver","pmids":["35443180"],"confidence":"High","gaps":["Direct HNF4A–GR physical interaction not demonstrated"]},{"year":2022,"claim":"Revealed HNF4A control of the liver–alpha-cell axis via direct regulation of the glucagon receptor.","evidence":"Liver-specific conditional knockout with ChIP, glucagon challenge, and metabolic phenotyping","pmids":["36464036"],"confidence":"High","gaps":["Contribution to systemic glucose homeostasis vs local effects not fully separated"]},{"year":2022,"claim":"Extended HNF4A function to immune crosstalk, directly regulating butyrophilin and MHC-like genes controlling intraepithelial lymphocyte populations.","evidence":"IEC-specific conditional knockout, ChIP, and flow cytometry of IEL populations, with human conservation","pmids":["35792863"],"confidence":"High","gaps":["Mechanism by which BTNL signals shape IEL selection not addressed here"]},{"year":2023,"claim":"Mapped tissue-dependent HNF4A target repertoires and distinguished the functional consequences of a T2D-associated variant from MODY1 loss-of-function alleles.","evidence":"ChIP-seq in pancreatic and hepatic cells with functional validation and variant comparison","pmids":["38909044"],"confidence":"High","gaps":["Mechanism by which rs1800961 alters DNA-binding affinity not directly measured"]},{"year":2023,"claim":"Validated HNF4A as the dominant paralog for proximal tubule brush border identity in human kidney organoids.","evidence":"HNF4A/HNF4G knockout iPSC kidney organoids, CUT&RUN, CRISPRa, RNA-seq, and EM","pmids":["37488681"],"confidence":"High","gaps":["Why HNF4A but not HNF4G is required in this context not resolved"]},{"year":2023,"claim":"Showed HNF4 paralogs activate mimetic-cell enhancers in thymic epithelium to recapitulate peripheral tissue gene programs for tolerance.","evidence":"Conditional Hnf4a/g knockout in TECs with scRNA-seq, ATAC-seq, ChIP, and CTCF analysis","pmids":["37399024"],"confidence":"High","gaps":["Mechanism linking HNF4-driven enhancers to CTCF redistribution unresolved"]},{"year":2024,"claim":"Established HNF4A as a basal repressor of acute-phase genes whose loss permits inflammatory derepression, defining a chromatin-gating role.","evidence":"Liver organoid HNF4A overexpression with chromatin accessibility and transcriptome profiling","pmids":["38755249"],"confidence":"Medium","gaps":["Single lab organoid model","Mechanism of chromatin retention at acute-phase loci not resolved"]},{"year":null,"claim":"How HNF4A switches between activator and repressor states at distinct loci, and how post-translational modifications and cofactor competition mechanistically direct enhancer looping, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking acetylation/phosphorylation status to genomic outcome","Direct mediators of HNF4A-dependent chromatin looping not identified","Structural basis of activator vs repressor switching unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,10,11,18,20,29,31]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,2,4,8,13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,8,23]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,23]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,13,26]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,5,12,21,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,19,20,27]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[26,27,28,35]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[18]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[24]}],"complexes":[],"partners":["NR2F2","FOXA2","GABP","DDX3X","SMAD4","CREBBP","NR0B2","TCF7L2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P41235","full_name":"Hepatocyte nuclear factor 4-alpha","aliases":["Nuclear receptor subfamily 2 group A member 1","Transcription factor 14","TCF-14","Transcription factor HNF-4"],"length_aa":474,"mass_kda":52.8,"function":"Transcriptional regulator which controls the expression of hepatic genes during the transition of endodermal cells to hepatic progenitor cells, facilitating the recruitment of RNA pol II to the promoters of target genes (PubMed:30597922). Activates the transcription of CYP2C38 (By similarity). Represses the CLOCK-BMAL1 transcriptional activity and is essential for circadian rhythm maintenance and period regulation in the liver and colon cells (PubMed:30530698)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P41235/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HNF4A","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HNF4A","total_profiled":1310},"omim":[{"mim_id":"617509","title":"VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 8; VWA8","url":"https://www.omim.org/entry/617509"},{"mim_id":"616511","title":"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14","url":"https://www.omim.org/entry/616511"},{"mim_id":"616477","title":"NUCLEAR RECEPTOR-BINDING FACTOR 2; NRBF2","url":"https://www.omim.org/entry/616477"},{"mim_id":"616026","title":"FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4","url":"https://www.omim.org/entry/616026"},{"mim_id":"613555","title":"TET METHYLCYTOSINE DIOXYGENASE 3; TET3","url":"https://www.omim.org/entry/613555"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":96.1},{"tissue":"kidney","ntpm":42.7},{"tissue":"liver","ntpm":112.7}],"url":"https://www.proteinatlas.org/search/HNF4A"},"hgnc":{"alias_symbol":["NR2A1","HNF4"],"prev_symbol":["TCF14","MODY","MODY1"]},"alphafold":{"accession":"P41235","domains":[{"cath_id":"3.30.50.10","chopping":"68-128","consensus_level":"high","plddt":97.1007,"start":68,"end":128},{"cath_id":"1.10.565.10","chopping":"151-374","consensus_level":"high","plddt":92.7537,"start":151,"end":374}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P41235","model_url":"https://alphafold.ebi.ac.uk/files/AF-P41235-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P41235-F1-predicted_aligned_error_v6.png","plddt_mean":73.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HNF4A","jax_strain_url":"https://www.jax.org/strain/search?query=HNF4A"},"sequence":{"accession":"P41235","fasta_url":"https://rest.uniprot.org/uniprotkb/P41235.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P41235/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P41235"}},"corpus_meta":[{"pmid":"8945471","id":"PMC_8945471","title":"Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1).","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8945471","citation_count":985,"is_preprint":false},{"pmid":"9832509","id":"PMC_9832509","title":"GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9832509","citation_count":534,"is_preprint":false},{"pmid":"9371825","id":"PMC_9371825","title":"The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9371825","citation_count":335,"is_preprint":false},{"pmid":"15761495","id":"PMC_15761495","title":"The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15761495","citation_count":188,"is_preprint":false},{"pmid":"31759926","id":"PMC_31759926","title":"HNF4 Regulates Fatty Acid Oxidation and Is Required for Renewal of Intestinal Stem Cells in Mice.","date":"2019","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/31759926","citation_count":180,"is_preprint":false},{"pmid":"2404717","id":"PMC_2404717","title":"Scope and heterogeneous nature of MODY.","date":"1990","source":"Diabetes care","url":"https://pubmed.ncbi.nlm.nih.gov/2404717","citation_count":162,"is_preprint":false},{"pmid":"31360071","id":"PMC_31360071","title":"Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment.","date":"2019","source":"Diabetes, metabolic syndrome and obesity : targets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31360071","citation_count":148,"is_preprint":false},{"pmid":"7873404","id":"PMC_7873404","title":"Characterization of the mouse HNF-4 gene and its expression during mouse embryogenesis.","date":"1994","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/7873404","citation_count":146,"is_preprint":false},{"pmid":"34453962","id":"PMC_34453962","title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model.","date":"2021","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/34453962","citation_count":132,"is_preprint":false},{"pmid":"33292863","id":"PMC_33292863","title":"The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY).","date":"2020","source":"Clinical diabetes and endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/33292863","citation_count":131,"is_preprint":false},{"pmid":"30988513","id":"PMC_30988513","title":"A reinforcing HNF4-SMAD4 feed-forward module stabilizes enterocyte identity.","date":"2019","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30988513","citation_count":125,"is_preprint":false},{"pmid":"25581748","id":"PMC_25581748","title":"Maturity-onset diabetes of the young (MODY): an update.","date":"2015","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/25581748","citation_count":124,"is_preprint":false},{"pmid":"10905494","id":"PMC_10905494","title":"Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels.","date":"2000","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10905494","citation_count":120,"is_preprint":false},{"pmid":"7789636","id":"PMC_7789636","title":"Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20.","date":"1995","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/7789636","citation_count":119,"is_preprint":false},{"pmid":"32583173","id":"PMC_32583173","title":"Treatment Options for MODY Patients: A Systematic Review of Literature.","date":"2020","source":"Diabetes therapy : research, treatment and education of diabetes and related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32583173","citation_count":113,"is_preprint":false},{"pmid":"32402285","id":"PMC_32402285","title":"HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32402285","citation_count":113,"is_preprint":false},{"pmid":"9754819","id":"PMC_9754819","title":"Mutation screening in 18 Caucasian families suggest the existence of other MODY genes.","date":"1998","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/9754819","citation_count":110,"is_preprint":false},{"pmid":"10627496","id":"PMC_10627496","title":"HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1).","date":"2000","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/10627496","citation_count":110,"is_preprint":false},{"pmid":"9313765","id":"PMC_9313765","title":"Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY.","date":"1997","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9313765","citation_count":105,"is_preprint":false},{"pmid":"2689121","id":"PMC_2689121","title":"Maturity-onset diabetes of the young (MODY).","date":"1989","source":"Diabetes/metabolism reviews","url":"https://pubmed.ncbi.nlm.nih.gov/2689121","citation_count":100,"is_preprint":false},{"pmid":"25263553","id":"PMC_25263553","title":"Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25263553","citation_count":94,"is_preprint":false},{"pmid":"15194767","id":"PMC_15194767","title":"Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein.","date":"2004","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/15194767","citation_count":91,"is_preprint":false},{"pmid":"24323243","id":"PMC_24323243","title":"De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed.","date":"2013","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/24323243","citation_count":90,"is_preprint":false},{"pmid":"27185732","id":"PMC_27185732","title":"The Drosophila HNF4 nuclear receptor promotes glucose-stimulated insulin secretion and mitochondrial function in adults.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27185732","citation_count":82,"is_preprint":false},{"pmid":"36257325","id":"PMC_36257325","title":"Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts.","date":"2022","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36257325","citation_count":76,"is_preprint":false},{"pmid":"19924231","id":"PMC_19924231","title":"Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19924231","citation_count":75,"is_preprint":false},{"pmid":"23499532","id":"PMC_23499532","title":"Fertility and germline stem cell maintenance under different diets requires nhr-114/HNF4 in C. elegans.","date":"2013","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/23499532","citation_count":73,"is_preprint":false},{"pmid":"30530698","id":"PMC_30530698","title":"Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30530698","citation_count":70,"is_preprint":false},{"pmid":"23761103","id":"PMC_23761103","title":"MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunction.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/23761103","citation_count":68,"is_preprint":false},{"pmid":"18356407","id":"PMC_18356407","title":"The diabetic phenotype in HNF4A mutation carriers is moderated by the expression of HNF4A isoforms from the P1 promoter during fetal development.","date":"2008","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18356407","citation_count":66,"is_preprint":false},{"pmid":"32528556","id":"PMC_32528556","title":"Update on clinical screening of maturity-onset diabetes of the young (MODY).","date":"2020","source":"Diabetology & metabolic syndrome","url":"https://pubmed.ncbi.nlm.nih.gov/32528556","citation_count":65,"is_preprint":false},{"pmid":"9294105","id":"PMC_9294105","title":"Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene.","date":"1997","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9294105","citation_count":64,"is_preprint":false},{"pmid":"30046000","id":"PMC_30046000","title":"Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/30046000","citation_count":62,"is_preprint":false},{"pmid":"31517624","id":"PMC_31517624","title":"Novel insights into genetics and clinics of the HNF1A-MODY.","date":"2019","source":"Endocrine regulations","url":"https://pubmed.ncbi.nlm.nih.gov/31517624","citation_count":61,"is_preprint":false},{"pmid":"32763092","id":"PMC_32763092","title":"Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review.","date":"2020","source":"Journal of diabetes and its complications","url":"https://pubmed.ncbi.nlm.nih.gov/32763092","citation_count":60,"is_preprint":false},{"pmid":"18184923","id":"PMC_18184923","title":"HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy.","date":"2008","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18184923","citation_count":58,"is_preprint":false},{"pmid":"19822575","id":"PMC_19822575","title":"Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19822575","citation_count":58,"is_preprint":false},{"pmid":"35638342","id":"PMC_35638342","title":"Precision diabetes: Lessons learned from maturity-onset diabetes of the young (MODY).","date":"2022","source":"Journal of diabetes investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35638342","citation_count":55,"is_preprint":false},{"pmid":"32216806","id":"PMC_32216806","title":"HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.","date":"2020","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32216806","citation_count":54,"is_preprint":false},{"pmid":"32093682","id":"PMC_32093682","title":"ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma.","date":"2020","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32093682","citation_count":54,"is_preprint":false},{"pmid":"32998360","id":"PMC_32998360","title":"Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32998360","citation_count":53,"is_preprint":false},{"pmid":"21403612","id":"PMC_21403612","title":"Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression.","date":"2010","source":"Experimental oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21403612","citation_count":53,"is_preprint":false},{"pmid":"12643132","id":"PMC_12643132","title":"Molecular etiologies of MODY and other early-onset forms of diabetes.","date":"2002","source":"Current diabetes reports","url":"https://pubmed.ncbi.nlm.nih.gov/12643132","citation_count":50,"is_preprint":false},{"pmid":"10389854","id":"PMC_10389854","title":"Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q).","date":"1999","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10389854","citation_count":49,"is_preprint":false},{"pmid":"37296105","id":"PMC_37296105","title":"HNF4A-BAP31-VDAC1 axis synchronously regulates cell proliferation and ferroptosis in gastric cancer.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37296105","citation_count":47,"is_preprint":false},{"pmid":"31195238","id":"PMC_31195238","title":"HNF4A Haploinsufficiency in MODY1 Abrogates Liver and Pancreas Differentiation from Patient-Derived Induced Pluripotent Stem Cells.","date":"2019","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/31195238","citation_count":47,"is_preprint":false},{"pmid":"32332020","id":"PMC_32332020","title":"Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32332020","citation_count":45,"is_preprint":false},{"pmid":"33078654","id":"PMC_33078654","title":"Mir214-3p and Hnf4a/Hnf4α reciprocally regulate Ulk1 expression and autophagy in nonalcoholic hepatic steatosis.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/33078654","citation_count":44,"is_preprint":false},{"pmid":"10551874","id":"PMC_10551874","title":"Mitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10551874","citation_count":42,"is_preprint":false},{"pmid":"35443180","id":"PMC_35443180","title":"HNF4A modulates glucocorticoid action in the liver.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35443180","citation_count":39,"is_preprint":false},{"pmid":"9604881","id":"PMC_9604881","title":"MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization.","date":"1998","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9604881","citation_count":39,"is_preprint":false},{"pmid":"34001900","id":"PMC_34001900","title":"The nuclear receptor HNF4 drives a brush border gene program conserved across murine intestine, kidney, and embryonic yolk sac.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34001900","citation_count":38,"is_preprint":false},{"pmid":"31345929","id":"PMC_31345929","title":"HNF4 factors control chromatin accessibility and are redundantly required for maturation of the fetal intestine.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31345929","citation_count":38,"is_preprint":false},{"pmid":"8632993","id":"PMC_8632993","title":"A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8632993","citation_count":38,"is_preprint":false},{"pmid":"10768098","id":"PMC_10768098","title":"Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients.","date":"2000","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/10768098","citation_count":37,"is_preprint":false},{"pmid":"30535056","id":"PMC_30535056","title":"Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.","date":"2019","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30535056","citation_count":37,"is_preprint":false},{"pmid":"38909044","id":"PMC_38909044","title":"HNF4A and HNF1A exhibit tissue specific target gene regulation in pancreatic beta cells and hepatocytes.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38909044","citation_count":35,"is_preprint":false},{"pmid":"30793219","id":"PMC_30793219","title":"Genetic Dissection and Clinical Features of MODY6 (NEUROD1-MODY).","date":"2019","source":"Current diabetes reports","url":"https://pubmed.ncbi.nlm.nih.gov/30793219","citation_count":35,"is_preprint":false},{"pmid":"27103109","id":"PMC_27103109","title":"Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?","date":"2016","source":"Canadian journal of diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27103109","citation_count":35,"is_preprint":false},{"pmid":"21683639","id":"PMC_21683639","title":"Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.","date":"2011","source":"Diabetes & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21683639","citation_count":35,"is_preprint":false},{"pmid":"37635981","id":"PMC_37635981","title":"Multiple roles and regulatory mechanisms of the transcription factor HNF4 in the intestine.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37635981","citation_count":33,"is_preprint":false},{"pmid":"17563455","id":"PMC_17563455","title":"HNF4A genetic variants: role in diabetes.","date":"2007","source":"Current opinion in clinical nutrition and metabolic care","url":"https://pubmed.ncbi.nlm.nih.gov/17563455","citation_count":33,"is_preprint":false},{"pmid":"11979019","id":"PMC_11979019","title":"Maturity-onset diabetes of the young (MODY): genetic and clinical characteristics.","date":"2002","source":"Hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/11979019","citation_count":33,"is_preprint":false},{"pmid":"17996499","id":"PMC_17996499","title":"Expression of HNF-4alpha (MODY1), HNF-1beta (MODY5), and HNF-1alpha (MODY3) proteins in the developing mouse pancreas.","date":"2007","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/17996499","citation_count":32,"is_preprint":false},{"pmid":"28648900","id":"PMC_28648900","title":"TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28648900","citation_count":32,"is_preprint":false},{"pmid":"31875549","id":"PMC_31875549","title":"Molecular Basis for Autosomal-Dominant Renal Fanconi Syndrome Caused by HNF4A.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31875549","citation_count":30,"is_preprint":false},{"pmid":"30317608","id":"PMC_30317608","title":"Identification of TAF1, HNF4A, and CALM2 as potential therapeutic target genes for liver fibrosis.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30317608","citation_count":29,"is_preprint":false},{"pmid":"35940258","id":"PMC_35940258","title":"AMPKα2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35940258","citation_count":28,"is_preprint":false},{"pmid":"15794920","id":"PMC_15794920","title":"The role of HNF4A variants in the risk of type 2 diabetes.","date":"2005","source":"Current diabetes reports","url":"https://pubmed.ncbi.nlm.nih.gov/15794920","citation_count":28,"is_preprint":false},{"pmid":"24711169","id":"PMC_24711169","title":"HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma.","date":"2014","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24711169","citation_count":27,"is_preprint":false},{"pmid":"33129248","id":"PMC_33129248","title":"Clinical implications of the glucokinase impaired function - GCK MODY today.","date":"2020","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/33129248","citation_count":27,"is_preprint":false},{"pmid":"29243296","id":"PMC_29243296","title":"Role of conventional immunomarkers, HNF4-α and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomas.","date":"2018","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/29243296","citation_count":27,"is_preprint":false},{"pmid":"37488681","id":"PMC_37488681","title":"Elucidating the Proximal Tubule HNF4A Gene Regulatory Network in Human Kidney Organoids.","date":"2023","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/37488681","citation_count":26,"is_preprint":false},{"pmid":"19478207","id":"PMC_19478207","title":"Control of ACAT2 liver expression by HNF4{alpha}: lesson from MODY1 patients.","date":"2009","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19478207","citation_count":26,"is_preprint":false},{"pmid":"29990710","id":"PMC_29990710","title":"Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs.","date":"2018","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29990710","citation_count":26,"is_preprint":false},{"pmid":"10819248","id":"PMC_10819248","title":"R127W-HNF-4alpha is a loss of function mutation but not a rare polymorphism and causes Type II diabetes in a Japanese family with MODY1.","date":"2000","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/10819248","citation_count":26,"is_preprint":false},{"pmid":"33503426","id":"PMC_33503426","title":"Three-dimensional interactions between enhancers and promoters during intestinal differentiation depend upon HNF4.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33503426","citation_count":26,"is_preprint":false},{"pmid":"28128295","id":"PMC_28128295","title":"RNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28128295","citation_count":26,"is_preprint":false},{"pmid":"36872411","id":"PMC_36872411","title":"TUBB2B facilitates progression of hepatocellular carcinoma by regulating cholesterol metabolism through targeting HNF4A/CYP27A1.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36872411","citation_count":25,"is_preprint":false},{"pmid":"22944911","id":"PMC_22944911","title":"Regulation of neural stem cell differentiation by transcription factors HNF4-1 and MAZ-1.","date":"2012","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22944911","citation_count":25,"is_preprint":false},{"pmid":"35792863","id":"PMC_35792863","title":"Epithelial HNF4A shapes the intraepithelial lymphocyte compartment via direct regulation of immune signaling molecules.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35792863","citation_count":25,"is_preprint":false},{"pmid":"38755249","id":"PMC_38755249","title":"Downregulation of HNF4A enables transcriptomic reprogramming during the hepatic acute-phase response.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/38755249","citation_count":24,"is_preprint":false},{"pmid":"36464036","id":"PMC_36464036","title":"Impaired hepatic glucose metabolism and liver-α-cell axis in mice with liver-specific ablation of the Hepatocyte Nuclear Factor 4α (Hnf4a) gene.","date":"2022","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/36464036","citation_count":24,"is_preprint":false},{"pmid":"34988346","id":"PMC_34988346","title":"First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications.","date":"2021","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/34988346","citation_count":23,"is_preprint":false},{"pmid":"30012629","id":"PMC_30012629","title":"COL4A3 Gene Variants and Diabetic Kidney Disease in MODY.","date":"2018","source":"Clinical journal of the American Society of Nephrology : CJASN","url":"https://pubmed.ncbi.nlm.nih.gov/30012629","citation_count":22,"is_preprint":false},{"pmid":"35132353","id":"PMC_35132353","title":"HNF4A Regulates the Proliferation and Tumor Formation of Cervical Cancer Cells through the Wnt/β-Catenin Pathway.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/35132353","citation_count":22,"is_preprint":false},{"pmid":"32489678","id":"PMC_32489678","title":"Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends.","date":"2020","source":"Oman medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32489678","citation_count":22,"is_preprint":false},{"pmid":"8894490","id":"PMC_8894490","title":"Maturity onset diabetes of the young (MODY).","date":"1996","source":"Diabetic medicine : a journal of the British Diabetic Association","url":"https://pubmed.ncbi.nlm.nih.gov/8894490","citation_count":22,"is_preprint":false},{"pmid":"24405491","id":"PMC_24405491","title":"Glucokinase gene mutations (MODY 2) in Asian Indians.","date":"2014","source":"Diabetes technology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/24405491","citation_count":22,"is_preprint":false},{"pmid":"37404310","id":"PMC_37404310","title":"Structural insights into the HNF4 biology.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37404310","citation_count":21,"is_preprint":false},{"pmid":"18474611","id":"PMC_18474611","title":"The MODY1 gene for hepatocyte nuclear factor 4alpha and a feedback loop control COUP-TFII expression in pancreatic beta cells.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18474611","citation_count":21,"is_preprint":false},{"pmid":"20705777","id":"PMC_20705777","title":"Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes: a case report.","date":"2010","source":"Diabetes care","url":"https://pubmed.ncbi.nlm.nih.gov/20705777","citation_count":21,"is_preprint":false},{"pmid":"38513726","id":"PMC_38513726","title":"Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment.","date":"2024","source":"Progress in cardiovascular diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38513726","citation_count":21,"is_preprint":false},{"pmid":"39899681","id":"PMC_39899681","title":"Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39899681","citation_count":20,"is_preprint":false},{"pmid":"39629121","id":"PMC_39629121","title":"Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism.","date":"2024","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/39629121","citation_count":20,"is_preprint":false},{"pmid":"37399024","id":"PMC_37399024","title":"Hnf4 activates mimetic-cell enhancers to recapitulate gut and liver development within the thymus.","date":"2023","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37399024","citation_count":20,"is_preprint":false},{"pmid":"9162575","id":"PMC_9162575","title":"Maturity-onset diabetes of the young (MODY), MODY genes and non-insulin-dependent diabetes mellitus.","date":"1997","source":"Diabetes & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9162575","citation_count":20,"is_preprint":false},{"pmid":"27111119","id":"PMC_27111119","title":"When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes.","date":"2016","source":"The review of diabetic studies : RDS","url":"https://pubmed.ncbi.nlm.nih.gov/27111119","citation_count":18,"is_preprint":false},{"pmid":"10866048","id":"PMC_10866048","title":"Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene.","date":"2000","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10866048","citation_count":17,"is_preprint":false},{"pmid":"27583195","id":"PMC_27583195","title":"Claudin-based barrier differentiation in the colonic epithelial crypt niche involves Hopx/Klf4 and Tcf7l2/Hnf4-α cascades.","date":"2016","source":"Tissue barriers","url":"https://pubmed.ncbi.nlm.nih.gov/27583195","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50757,"output_tokens":9258,"usd":0.14557,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19376,"output_tokens":8243,"usd":0.151477,"stage2_stop_reason":"end_turn"},"total_usd":0.297047,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"HNF4A (TCF14) was identified as the MODY1 gene; it is a member of the steroid/thyroid hormone receptor superfamily and functions as an upstream transcriptional regulator of HNF-1alpha expression, establishing its position in a transcriptional hierarchy governing pancreatic beta-cell function.\",\n      \"method\": \"Genetic linkage analysis, gene identification, positional cloning\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — landmark positional cloning study replicated across multiple labs; HNF4A's role as upstream regulator of HNF1A is a foundational finding independently confirmed\",\n      \"pmids\": [\"8945471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The MODY1 nonsense mutation Q268X causes loss of HNF4A transcriptional transactivation activity and abolishes dimerization and DNA binding. Loss of HNF4A function in embryonic stem cells-derived visceral endoderm reduces expression of glucose transporter 2, aldolase B, glyceraldehyde-3-phosphate dehydrogenase, liver pyruvate kinase, and fatty acid binding proteins, demonstrating HNF4A directly regulates glucose transport and glycolysis genes.\",\n      \"method\": \"Functional assays in mutant protein; embryonic stem cell visceral endoderm differentiation system; gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (mutant protein functional assay, genetic loss-of-function in ES cells, gene expression profiling); replicated conceptually by subsequent studies\",\n      \"pmids\": [\"9371825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The MODY1 Q268X mutant protein cannot bind DNA alone or as a dimer with wild-type HNF4A in EMSA, yet retains the ability to dimerize with wild-type HNF4A in solution (co-immunoprecipitation). Despite dimerization, it does not exert dominant-negative transcriptional effects in vivo; instead it shows striking cytoplasmic/insoluble localization (extractable only with SDS), suggesting MODY1 phenotype results from loss of functional nuclear HNF4A, particularly pronounced in pancreas where HNF4A levels are low.\",\n      \"method\": \"EMSA, co-immunoprecipitation, transient transfection, subcellular fractionation/immunofluorescence\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal methods (EMSA, co-IP, transfection, localization) in single study; mechanistically precise\",\n      \"pmids\": [\"9604881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GATA6 lies upstream of HNF4A in a transcriptional cascade required for visceral endoderm differentiation: GATA6-deficient embryos lack HNF4 gene expression, and forced GATA6 expression activates the HNF4 promoter in non-endodermal cells.\",\n      \"method\": \"Gene targeting (GATA6 knockout ES cells and mice), promoter activation assay, in situ hybridization\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function plus gain-of-function promoter assay; replicated in ES cells and whole-animal knockout\",\n      \"pmids\": [\"9832509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The MODY1 missense mutation HNF4(E276Q) is a loss-of-function mutation: it cannot bind HNF-4 consensus DNA sites or activate transcription. A truncated 40-kDa C-terminal product of E276Q can co-immunoprecipitate with wild-type HNF4A and exerts weak dominant-negative activity in non-beta-cell types. Glutamic acid 276 in helix 8 of the LBD is identified as critical for DNA binding, transactivation, and protein stability. HNF4(R127W) and HNF4(V255M) show transactivation indistinguishable from wild-type.\",\n      \"method\": \"Transcriptional activation assay, EMSA, co-immunoprecipitation, Western blot, cell-type-specific transfection\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal biochemical methods (EMSA, co-IP, transactivation, Western) in single rigorous study\",\n      \"pmids\": [\"10389854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HNF4 regulates apolipoprotein CIII (apoCIII) gene transcription through a DR1 binding site at position -746 in the apoCIII promoter. MAP kinase signaling modulates apoCIII expression partly via changes in HNF4 mRNA and protein levels; repression of MAP kinase increases HNF4 expression and apoCIII transcription.\",\n      \"method\": \"Transient transfection/reporter assay in HepG2, EMSA, promoter deletion mapping, pharmacological MAP kinase inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus reporter assay, single lab; MAP kinase regulation of HNF4 expression is a secondary inference\",\n      \"pmids\": [\"10551874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HNF4 and COUP-TFII synergistically activate transcription of the CYP7A1 (cholesterol 7alpha-hydroxylase) promoter. HNF4 binds a DR1 element at nt -146 to -134 of the CYP7A1 promoter, and synergy with COUP-TFII involves protein-protein interactions facilitated by juxtaposed binding elements rather than requiring independent COUP-TFII DNA binding.\",\n      \"method\": \"EMSA with rat liver nuclear extracts, cotransfection assays in HepG2, site-directed mutagenesis of promoter elements\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA, cotransfection, mutagenesis in single lab; protein-protein interaction inference based on functional data\",\n      \"pmids\": [\"10627496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HNF4A haploinsufficiency (not hyperglycemia) is the primary cause of reduced serum levels of apolipoprotein AII, apoCIII, lipoprotein(a), and triglycerides in MODY1 mutation carriers, demonstrating HNF4A is a required transcriptional regulator of these hepatic secretory proteins in vivo.\",\n      \"method\": \"Serum protein measurement in genotyped MODY1 pedigree members (diabetic HNF4+/-, nondiabetic HNF4+/-, normal HNF4+/+); genetic haploinsufficiency analysis\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — carefully controlled human genetics study with multiple protein measurements; single family pedigree\",\n      \"pmids\": [\"10905494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The R127W-HNF4A mutation reduces DNA binding ability and transcriptional activation of HNF-1alpha and L-type pyruvate kinase (PKL) genes; nuclear import and functional synergy with coactivator CBP are normal, confirming R127W is a loss-of-function mutation.\",\n      \"method\": \"Transcriptional activation assay, EMSA, co-immunoprecipitation with CBP, immunofluorescence for nuclear localization\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays, single lab\",\n      \"pmids\": [\"10819248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HNF4 stimulates expression of the precore RNA and core RNA from the hepatitis B virus (HBV) core promoter by binding to a nuclear receptor binding site; this effect is more prominent on the wild-type than on the A1762T/G1764A double-mutant core promoter. The X protein does not affect HNF4 activity on the core promoter.\",\n      \"method\": \"Reporter assay in Huh7 hepatoma cells, cotransfection, HBV genomic constructs with/without X protein\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assays with multiple constructs, single lab\",\n      \"pmids\": [\"15194767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HNF4A is required in pancreatic beta cells for regulation of the ATP-dependent potassium channel pathway of insulin secretion; conditional beta-cell knockout mice show hyperinsulinemia but impaired glucose tolerance, with ~60% reduction in Kir6.2 (KCNJ11) expression. Cotransfection assays demonstrate Kir6.2 is a direct transcriptional target of HNF4A.\",\n      \"method\": \"Cre-loxP conditional knockout, islet perifusion, calcium imaging, cotransfection assay, quantitative gene expression\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional knockout with defined physiological phenotype plus in vitro transcriptional target validation; multiple orthogonal methods\",\n      \"pmids\": [\"15761495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HNF4A directly activates the COUP-TFII (NR2F2) promoter via a DR-1 binding site in pancreatic beta cells (demonstrated by ChIP and reporter/mutagenesis), and COUP-TFII in turn positively regulates HNF4A mRNA levels, forming a positive feedback loop. COUP-TFII also autorepreses its own promoter via the same DR-1 site.\",\n      \"method\": \"ChIP, promoter reporter assay, site-directed mutagenesis, dominant-negative suppression, siRNA knockdown, adenoviral overexpression in 832/13 INS-1 cells and mouse islets\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP plus mutagenesis plus gain/loss-of-function in both cell line and primary islets; multiple orthogonal methods\",\n      \"pmids\": [\"18474611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HNF4A binds to and regulates the hepatocyte-specific expression of the ACAT2 (cholesterol esterification enzyme) promoter, as confirmed by ChIP assay in human liver and site-directed mutagenesis of an HNF4 binding site; HNF4A can act directly or indirectly via HNF1alpha. MODY1 patients have lower VLDL and LDL esterified cholesterol consistent with reduced ACAT2 activity.\",\n      \"method\": \"ChIP assay in human liver, mutagenesis, cotransfection in HuH7 cells, lipoprotein profiling in MODY1 patients\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP in human tissue plus mutagenesis plus human clinical validation; multiple orthogonal methods\",\n      \"pmids\": [\"19478207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Genome-wide ChIP-seq reveals HNF4A binds ~18,783 peaks in hepatic cells, predominantly at non-promoter positions (90% distal elements). HNF4A co-occupies sites with FOXA2, and an HNF4A–GABP interaction at transcription start sites was identified and verified by co-immunoprecipitation.\",\n      \"method\": \"ChIP-seq, co-immunoprecipitation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus co-IP, single lab\",\n      \"pmids\": [\"19822575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In mouse liver development, HNF4A binding to enhancers is differentiation-dependent, with embryonic enhancers responsive to TEAD2/YAP1 (Hippo signaling). Hippo pathway activity influences which temporal enhancers HNF4A and FOXA2 occupy during hepatocyte differentiation.\",\n      \"method\": \"ChIP-seq in vivo across developmental stages, chromatin remodeling analysis, gene expression profiling\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq in vivo, single lab; functional validation of Hippo-HNF4A link is indirect\",\n      \"pmids\": [\"25263553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Drosophila HNF4 (dHNF4) is required in the fat body and insulin-producing cells for a developmental switch toward oxidative phosphorylation and glucose-stimulated insulin secretion at the adult transition. Loss of dHNF4 causes adult-onset hyperglycemia, glucose intolerance, and impaired GSIS, linked to reduced mitochondrial function and decreased expression of Hex-C (glucokinase homolog).\",\n      \"method\": \"Drosophila genetic loss-of-function, metabolic assays, glucose tolerance test, insulin secretion assay, gene expression\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo animal model with defined genetic loss-of-function and multiple physiological phenotypic readouts; well-controlled Drosophila ortholog study\",\n      \"pmids\": [\"27185732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DDX3 RNA helicase interacts with HNF4A and co-activates HNF4A-mediated transactivation of the MTP (microsomal triglyceride transfer protein) promoter. DDX3 enhances HNF4A acetylation via CBP/p300 interaction, increases HNF4A promoter binding affinity, and competes with the repressor SHP for HNF4A binding, disrupting the inactive HNF4A/SHP heterodimer and promoting active HNF4A homodimer formation.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assay, ChIP, ATPase activity assay, siRNA knockdown\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ChIP, reporter assay with mutagenesis approach; single lab, multiple methods\",\n      \"pmids\": [\"28128295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TET-catalyzed 5-hydroxymethylation (5hmC) at the HNF4A P1 promoter precedes expression of P1 promoter-derived HNF4A isoforms during hepatocyte differentiation. TET dioxygenases and the pioneer factor FOXA2 are required for 5hmC at P1 and subsequent P1-driven HNF4A expression; FOXA2 is necessary for TET1 binding to the P1 locus.\",\n      \"method\": \"5hmC/5mC mapping, TET inhibition, FOXA2 knockdown, in vitro hepatocyte differentiation model\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epigenetic mapping plus functional knockdown experiments in differentiation model; single lab\",\n      \"pmids\": [\"28648900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HNF4A strongly transrepresses CLOCK:BMAL1 heterodimer transcriptional activity, defining a negative feedback loop in the hepatic circadian clock. Genome-wide ChIP-seq shows HNF4A binding at CLOCK:BMAL1 co-occupied metabolic gene loci is rhythmic in mouse liver. HNF4A maintains cell-autonomous circadian oscillations in a tissue-specific manner in liver and colon cells.\",\n      \"method\": \"Transcriptional reporter assay (transrepression), ChIP-seq, circadian oscillation assay (luciferase reporter), cell-autonomous oscillation measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus functional transrepression assay plus cell-autonomous oscillation experiments; multiple orthogonal methods, single lab\",\n      \"pmids\": [\"30530698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Kidney-specific deletion of Hnf4a in mice causes Fanconi renotubular syndrome-like phenotype (polyuria, polydipsia, glycosuria, phosphaturia) with failure of proximal tubule differentiation and loss of proximal tubule-specific gene expression; Hnf4a is required for differentiated but not presumptive proximal tubule formation.\",\n      \"method\": \"Conditional kidney-specific Hnf4a knockout mice, histology, gene expression, physiological phenotyping\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional knockout with multiple defined phenotypic readouts; well-controlled study\",\n      \"pmids\": [\"30046000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HNF4A and SMAD4 form a reinforcing feed-forward loop in the intestine: they activate each other's expression and co-bind regulatory elements of differentiation genes. Double knockout of HNF4A and its paralog HNF4G abolishes enterocyte differentiation; HNF4 activates enhancer chromatin and upregulates the majority of transcripts enriched in differentiated intestinal epithelium.\",\n      \"method\": \"Double conditional knockout (HNF4A/HNF4G), ChIP-seq, ATAC-seq, RNA-seq, gene expression profiling\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo double knockout plus genome-wide ChIP-seq and chromatin accessibility; multiple orthogonal methods\",\n      \"pmids\": [\"30988513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HNF4A and HNF4G are required for intestinal stem cell renewal via direct transcriptional activation of fatty acid oxidation (FAO) genes including Acsl5, Acsf2, Slc27a2, Fabp2, and Hadh. Loss of both paralogs reduces FAO activity, TCA cycle metabolites, and Lgr5+ stem cell markers; restoration of acetyl-CoA via acetate or dichloroacetate rescues stem cells.\",\n      \"method\": \"Double conditional knockout (Hnf4a/Hnf4g), ChIP-seq, metabolic assays (FAO activity, TCA metabolites), isotope tracing, organoid rescue experiments\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo double knockout plus ChIP-seq plus metabolic tracing plus organoid rescue; multiple orthogonal methods\",\n      \"pmids\": [\"31759926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The HNF4A p.Ile271fs MODY1 mutant does not undergo complete nonsense-mediated decay and does not exert dominant negativity; loss of function is due to impaired transcriptional activation of target genes. MODY1-iPSC-derived hepatopancreatic progenitors with reduced HNF4A show downregulation of foregut genes and upregulation of hindgut HOX genes.\",\n      \"method\": \"Patient-derived iPSC differentiation, gene expression profiling, HNF4A localization by immunofluorescence\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — iPSC model with gene expression profiling; single lab, mechanistic interpretation is partly inferential\",\n      \"pmids\": [\"31195238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The FRTS-associated HNF4A R85W mutation (in the DNA-binding domain) causes nuclear depletion and cytosolic aggregation of wild-type dHNF4 protein in Drosophila nephrocytes. Nuclear depletion leads to mitochondrial defects and lipid droplet accumulation; cytosolic aggregates trigger ER expansion, autophagy, and cell death. Blocking serine phosphorylation in the DBD prevents nuclear export and rescues the cytosolic aggregation phenotype.\",\n      \"method\": \"Drosophila nephrocyte expression system, confocal microscopy, electron microscopy, phosphorylation site mutagenesis, genetic rescue\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic mutagenesis rescue plus in vivo cellular phenotyping with multiple readouts; well-controlled Drosophila ortholog study\",\n      \"pmids\": [\"31875549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mir214-3p suppresses Ulk1 expression by direct binding to the 3' UTR of Ulk1, while HNF4A (Hnf4a) directly activates Ulk1 transcription (demonstrated by ChIP). In nonalcoholic fatty liver, increased Mir214-3p and decreased Hnf4a reduce autophagic activity; silencing Mir214-3p increases Ulk1 and autophagic flux, but not under Ulk1 suppression, placing HNF4A upstream of ULK1-mediated autophagy.\",\n      \"method\": \"ChIP (HNF4A binding to Ulk1 promoter), luciferase 3'UTR assay, LNA-mediated miRNA silencing, autophagy flux assays in mouse liver\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus functional epistasis in vivo; single lab\",\n      \"pmids\": [\"33078654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Therapeutic delivery of HNF4A mRNA via lipid nanoparticles to mouse liver attenuates fibrosis in four independent models. Paraoxonase 1 (PON1) was identified as a direct HNF4A transcriptional target by ChIP; PON1 contributes to HNF4A-mediated anti-fibrotic effect via modulation of liver macrophages and hepatic stellate cells.\",\n      \"method\": \"LNP-mediated mRNA delivery in vivo, ChIP, microarray/scRNA-seq, primary cell experiments, human liver bud model\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-validated direct target plus in vivo functional rescue in multiple independent models plus single-cell mechanistic dissection\",\n      \"pmids\": [\"34453962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HNF4 transcription factors are required for chromatin looping between enhancers and promoters at target genes in the intestinal epithelium. HNF4 depletion disrupts local enhancer-promoter chromatin interactions, histone modifications, and target gene expression; despite dynamic gene regulation during differentiation, enhancer-promoter loops are relatively stable.\",\n      \"method\": \"H3K4me3 HiChIP-seq, ATAC-seq, ChIP-seq, conditional HNF4 knockout\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — HiChIP-seq plus ChIP-seq plus genetic loss-of-function; multiple orthogonal genome-wide methods\",\n      \"pmids\": [\"33503426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HNF4 (HNF4A and HNF4G) drives a conserved brush border gene program in intestine, kidney, and yolk sac by directly binding and activating brush border genes. HNF4 loss results in impaired chromatin looping between enhancers and promoters at brush border gene loci and enhanced looping at stress fiber gene loci.\",\n      \"method\": \"Conditional knockout (intestine, kidney, yolk sac), ChIP-seq, H3K4me3 HiChIP-seq, RNA-seq, transport assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus HiChIP plus genetic loss-of-function across multiple organs; multiple orthogonal methods\",\n      \"pmids\": [\"34001900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HNF4A defines liver-specific glucocorticoid receptor (GR) action by acting as a lineage-determining factor: the HNF4A motif lies adjacent to glucocorticoid response elements at GR binding sites in open chromatin. In Hnf4a-null liver, the GR cistrome is remodeled—loss of GR recruitment occurs at weak GRE sites with HNF4A-marked chromatin, while GR binding is gained at strong GRE motifs normally restricted to non-liver tissues.\",\n      \"method\": \"ChIP-seq (GR, HNF4A), ATAC-seq in Hnf4a-null liver, transcriptional response analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq plus ATAC-seq in conditional knockout; multiple orthogonal methods clearly establishing mechanism\",\n      \"pmids\": [\"35443180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HNF4A directly regulates the glucagon receptor (Gcgr) gene in mouse liver (confirmed by ChIP); liver-specific Hnf4a knockout mice show markedly reduced Gcgr expression, glucagon resistance, alpha-cell hyperplasia, and dramatically elevated glucagon levels, revealing a role for HNF4A in controlling the liver-alpha-cell axis and blood glucose homeostasis.\",\n      \"method\": \"Liver-specific conditional Hnf4a knockout (Alb-Cre), ChIP assay, glucagon challenge test, metabolic phenotyping, gene expression\",\n      \"journal\": \"Metabolism: clinical and experimental\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-validated direct target plus in vivo conditional knockout with well-defined physiological phenotype\",\n      \"pmids\": [\"36464036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HNF4A in intestinal epithelial cells directly regulates expression of immune signaling molecules Btnl1, Btnl6, H2-T3, and Clec2e that control epithelial-intraepithelial lymphocyte (IEL) crosstalk, selectively expanding TCRγδ+ and TCRαβ+CD8αα+ natural IELs; in the small intestine HNF4A cooperates with HNF4G for this function. The HNF4A-BTNL regulatory axis is conserved in human IECs.\",\n      \"method\": \"IEC-specific conditional knockout, ChIP, gene expression, flow cytometry of IEL populations\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional knockout plus ChIP demonstrating direct regulation; functional immune phenotype measured; conservation in human IECs\",\n      \"pmids\": [\"35792863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HNF4A binds and directly regulates known targets (ACY3, HAAO, HNF1A, MAP3K11) and previously unidentified loci (ABCD3, CDKN2AIP, USH1C, VIL1) in a tissue-dependent manner in pancreatic beta cells and hepatocytes. The T2D-associated HNF4A variant rs1800961 (unlike the loss-of-function MODY1 variant I271fs) activates AKAP1, GAD2, and HOPX expression, potentially through altered DNA-binding affinity.\",\n      \"method\": \"ChIP-seq in pancreatic and hepatic cells, functional validation of selected targets, comparison of MODY1 vs T2D variants\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq with functional follow-up across cell types; multiple orthogonal approaches in single rigorous study\",\n      \"pmids\": [\"38909044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HNF4A directly regulates its target genes in human proximal tubules (validated by CUT&RUN sequencing showing binding at promoters and enhancers of downregulated genes). HNF4A loss (not HNF4G) in human kidney organoids impairs expression of transport-related, endocytosis-related, and brush border genes and disorganizes apical brush border structure. CRISPRa-mediated induction of HNF4A or HNF4G drives increased expression of selected target genes.\",\n      \"method\": \"HNF4A/HNF4G knockout iPSC-derived kidney organoids, CUT&RUN sequencing, CRISPRa, RNA-seq, electron microscopy\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human organoid KO plus CUT&RUN genome-wide binding plus CRISPRa gain-of-function; multiple orthogonal methods\",\n      \"pmids\": [\"37488681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HNF4A binds to and represses acute-phase response genes under basal hepatic conditions. During inflammation, loss of HNF4A function is required for derepression of acute-phase genes; overexpression of HNF4A in liver organoids retains chromatin at regulatory regions of acute-phase genes inaccessible to transcription, potently impairing the acute-phase response while maintaining hepatocyte functionality.\",\n      \"method\": \"Pre-clinical liver organoid model, HNF4A overexpression, chromatin accessibility assay, transcriptome profiling\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — organoid gain-of-function plus chromatin accessibility; single lab, liver organoid model\",\n      \"pmids\": [\"38755249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In the colonic epithelium, HNF4A cooperates with TCF7L2 in a cascade that upregulates Claudin-23 expression during differentiation, as confirmed by ChIP and Hnf4a conditional knockout mice (which fail to induce Cldn23).\",\n      \"method\": \"ChIP, microarray/gene expression, in vitro cotransfection, Hnf4a conditional knockout mice\",\n      \"journal\": \"Tissue barriers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus in vivo conditional KO confirmation; single lab, limited to one target gene\",\n      \"pmids\": [\"27583195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In medullary thymic epithelial cells (mTECs), HNF4α and HNF4γ activate mimetic-cell enhancers to recapitulate entero-hepato gene expression programs, with HNF4γ providing primary contribution. Loss of both Hnf4 paralogs ablates entero-hepato mTECs, impairs enhancer activation and CTCF redistribution, but does not affect Polycomb repression or promoter-proximal histone marks.\",\n      \"method\": \"Conditional Hnf4α/γ knockout in TECs, scRNA-seq, ATAC-seq, ChIP, CTCF binding analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional knockout plus scRNA-seq plus ATAC-seq plus ChIP; multiple orthogonal methods\",\n      \"pmids\": [\"37399024\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HNF4A is a nuclear receptor transcription factor that functions as an obligate homodimer binding DR1 elements to activate a broad transcriptional program in liver, intestine, kidney, and pancreatic beta cells; it acts as an upstream activator of HNF1A, directly transactivates genes governing glucose transport/glycolysis (GLUT2, aldolase B, GAPDH, pyruvate kinase), fatty acid oxidation, lipoprotein metabolism (apoCIII, ACAT2, MTP), the glucagon receptor, and the ATP-sensitive K+ channel subunit Kir6.2 in beta cells, while also transrepressing CLOCK:BMAL1 circadian activity and acute-phase response genes; its activity is modulated by post-translational modifications (acetylation via CBP/p300 enhanced by DDX3, serine phosphorylation in the DBD controlling nuclear export), epigenetic control of promoter choice (TET-mediated 5hmC at P1 upstream of FOXA2), co-regulatory interactions with COUP-TFII (mutual positive feedback), SMAD4 (feed-forward loop in intestinal differentiation), and GABP; loss-of-function MODY1 mutations abolish DNA binding and transactivation, causing beta-cell dysfunction primarily through haploinsufficiency, while a specific DBD mutation (R85W) additionally triggers cytoplasmic aggregation and Fanconi renal tubular syndrome through a non-genomic mechanism.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HNF4A is a nuclear receptor transcription factor that sits at the apex of a tissue-restricted regulatory hierarchy, controlling differentiated cell identity and metabolic gene programs in liver, intestine, kidney, and pancreatic beta cells [#0, #1, #20]. It binds DR1 elements as a dimer and is positioned within a transcriptional cascade: GATA6 acts upstream to activate HNF4 in visceral endoderm, while HNF4A in turn drives HNF1A expression [#3, #0]. Genome-wide, HNF4A occupies predominantly distal enhancers, co-occupying chromatin with the pioneer factor FOXA2, and it is required to establish enhancer–promoter chromatin loops and accessible chromatin at its target loci [#13, #26, #20]. Through this enhancer-organizing role it directly activates broad metabolic and differentiation programs — glucose-handling and glycolytic genes (GLUT2, aldolase B, GAPDH, pyruvate kinase) [#1], hepatic lipoprotein and cholesterol genes including apoCIII, ACAT2, CYP7A1, and MTP [#5, #12, #6, #16], the beta-cell ATP-sensitive K+ channel subunit Kir6.2 driving insulin secretion [#10], the hepatic glucagon receptor governing the liver–alpha-cell axis [#29], and fatty acid oxidation genes that sustain intestinal stem cell renewal [#21]. HNF4A also acts as a lineage-determining factor that shapes glucocorticoid receptor binding in liver and as a transcriptional repressor of CLOCK:BMAL1 circadian activity and of hepatic acute-phase response genes [#28, #18, #33]. Its activity is reinforced by feedback and feed-forward loops with COUP-TFII (NR2F2) in beta cells and with SMAD4 in intestine, and is tuned by co-activators including DDX3, which enhances CBP/p300-mediated acetylation and displaces the SHP repressor to favor the active homodimer [#11, #20, #16]. Loss-of-function mutations in HNF4A cause MODY1 maturity-onset diabetes primarily through haploinsufficiency, with mutant proteins abolishing DNA binding and transactivation without exerting dominant-negative effects [#0, #1, #4, #22]; a DNA-binding-domain mutation (R85W) additionally produces a Fanconi renotubular syndrome phenotype via serine-phosphorylation-driven nuclear export and cytosolic aggregation [#23, #19].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established HNF4A's identity and its place in a transcriptional hierarchy, answering which gene underlies MODY1 and how it connects to beta-cell function.\",\n      \"evidence\": \"Positional cloning and genetic linkage in MODY1 pedigrees identifying HNF4A as an upstream regulator of HNF1A\",\n      \"pmids\": [\"8945471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct beta-cell target genes not yet defined\", \"Mechanism of upstream HNF1A regulation not resolved at the binding-site level\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Connected MODY1 loss-of-function to specific metabolic genes, showing HNF4A directly drives glucose transport and glycolytic gene expression.\",\n      \"evidence\": \"Functional assay of the Q268X mutant plus loss-of-function in ES-cell-derived visceral endoderm with gene expression profiling\",\n      \"pmids\": [\"9371825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of individual targets not separated\", \"Pancreatic relevance inferred from endoderm model\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Resolved whether MODY1 acts by dominant-negative interference or loss of function, and identified an aberrant subcellular fate of mutant protein.\",\n      \"evidence\": \"EMSA, co-immunoprecipitation, transfection, and subcellular fractionation of Q268X mutant\",\n      \"pmids\": [\"9604881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cause of cytoplasmic/insoluble localization not mechanistically defined\", \"Single mutant studied\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Placed HNF4A within a developmental cascade by identifying GATA6 as its upstream activator in visceral endoderm.\",\n      \"evidence\": \"GATA6 knockout ES cells/mice plus HNF4 promoter activation assay\",\n      \"pmids\": [\"9832509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect promoter activation by GATA6 not fully resolved\", \"Restricted to endoderm context\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapped a critical LBD residue (E276) for DNA binding, transactivation, and stability, and distinguished true loss-of-function from neutral MODY variants.\",\n      \"evidence\": \"Transactivation, EMSA, co-IP, and Western analysis of E276Q, R127W, and V255M mutants in multiple cell types\",\n      \"pmids\": [\"10389854\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Weak dominant-negative effect of truncated product not tested in beta cells in vivo\", \"Structural basis of E276 role not directly determined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated direct DR1-mediated regulation of a hepatic lipoprotein gene and a signaling input modulating HNF4A levels.\",\n      \"evidence\": \"Reporter assays, EMSA, promoter mapping, and MAP kinase inhibition in HepG2 for apoCIII\",\n      \"pmids\": [\"10551874\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MAP kinase control of HNF4A expression is a secondary inference\", \"Single cell line\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showed HNF4A synergizes with COUP-TFII at a lipid-metabolism promoter through protein–protein interaction rather than independent COUP-TFII DNA binding.\",\n      \"evidence\": \"EMSA, cotransfection, and promoter mutagenesis for CYP7A1 in HepG2\",\n      \"pmids\": [\"10627496\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical interaction inferred from functional data, not co-IP\", \"Single lab\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that the in vivo MODY1 lipid phenotype arises from haploinsufficiency rather than secondary hyperglycemia.\",\n      \"evidence\": \"Serum protein measurement across genotyped MODY1 pedigree members\",\n      \"pmids\": [\"10905494\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single family pedigree\", \"Direct transcriptional regulation of each serum protein not all demonstrated\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Confirmed R127W as loss-of-function affecting DNA binding while preserving nuclear import and CBP synergy, refining genotype–mechanism mapping.\",\n      \"evidence\": \"Transactivation, EMSA, co-IP with CBP, and immunofluorescence for HNF1A and PKL targets\",\n      \"pmids\": [\"10819248\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo beta-cell consequence not measured\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Linked HNF4A directly to the insulin secretion machinery by identifying Kir6.2 as a target underlying the beta-cell secretory phenotype.\",\n      \"evidence\": \"Beta-cell conditional knockout with perifusion/calcium imaging plus cotransfection target validation\",\n      \"pmids\": [\"15761495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of beta-cell targets explaining hyperinsulinemia not enumerated\", \"Direct binding by ChIP not shown in this study\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined a positive feedback circuit between HNF4A and COUP-TFII in beta cells, explaining transcriptional network stabilization.\",\n      \"evidence\": \"ChIP, reporter mutagenesis, siRNA, and adenoviral overexpression in INS-1 cells and islets\",\n      \"pmids\": [\"18474611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of COUP-TFII-mediated HNF4A upregulation not resolved\", \"Tissue-specificity of loop not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Provided the first genome-wide view showing HNF4A acts predominantly at distal enhancers and co-occupies sites with FOXA2 and GABP.\",\n      \"evidence\": \"ChIP-seq in hepatic cells plus co-immunoprecipitation\",\n      \"pmids\": [\"19822575\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of GABP interaction not dissected\", \"Single lab\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established HNF4A as a direct hepatic regulator of cholesterol esterification via ACAT2, with human clinical correlation.\",\n      \"evidence\": \"ChIP in human liver, promoter mutagenesis, cotransfection, and MODY1 lipoprotein profiling\",\n      \"pmids\": [\"19478207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of direct vs HNF1A-mediated regulation unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed HNF4A enhancer selection is developmentally dynamic and integrates Hippo (TEAD2/YAP1) signaling during hepatocyte differentiation.\",\n      \"evidence\": \"Developmental-stage ChIP-seq with chromatin and expression profiling in mouse liver\",\n      \"pmids\": [\"25263553\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional Hippo–HNF4A link is indirect\", \"Mechanism directing temporal enhancer choice unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated through the Drosophila ortholog that HNF4 drives a developmental metabolic switch toward oxidative phosphorylation and glucose-stimulated insulin secretion.\",\n      \"evidence\": \"Drosophila genetic loss-of-function with metabolic, glucose tolerance, and insulin secretion assays\",\n      \"pmids\": [\"27185732\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conservation of specific target genes in mammals not all established here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified cooperation with TCF7L2 to control an epithelial barrier gene during colonic differentiation.\",\n      \"evidence\": \"ChIP, expression profiling, cotransfection, and Hnf4a conditional knockout for Cldn23\",\n      \"pmids\": [\"27583195\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Limited to a single target gene\", \"Direct HNF4A–TCF7L2 interaction not shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed post-translational control of HNF4A: DDX3 promotes CBP/p300-mediated acetylation and shifts the equilibrium from the inactive SHP heterodimer to the active homodimer.\",\n      \"evidence\": \"Co-IP, ChIP, ATPase assay, and reporter/siRNA experiments on MTP regulation\",\n      \"pmids\": [\"28128295\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acetylation site mapping not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined epigenetic control of HNF4A promoter choice, showing FOXA2-dependent TET activity deposits 5hmC at the P1 promoter to enable P1 isoform expression.\",\n      \"evidence\": \"5hmC/5mC mapping, TET inhibition, and FOXA2 knockdown in a hepatocyte differentiation model\",\n      \"pmids\": [\"28648900\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional difference between P1 and P2 isoforms not tested here\", \"Single differentiation system\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified HNF4A as a transrepressor of CLOCK:BMAL1, integrating it into the hepatic circadian clock with rhythmic genomic binding.\",\n      \"evidence\": \"Transrepression reporter, ChIP-seq, and cell-autonomous oscillation assays in liver and colon cells\",\n      \"pmids\": [\"30530698\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of transrepression at the molecular level not resolved\", \"In vivo circadian phenotype of HNF4A loss not measured here\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established a non-diabetic, kidney-specific requirement for HNF4A in proximal tubule differentiation, modeling Fanconi renotubular syndrome.\",\n      \"evidence\": \"Kidney-specific conditional knockout with histology, expression, and physiological phenotyping\",\n      \"pmids\": [\"30046000\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct proximal-tubule target genes not all defined here\", \"Distinction from presumptive tubule formation mechanism unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a reinforcing HNF4A–SMAD4 feed-forward loop and showed HNF4A/HNF4G redundancy is essential for enterocyte differentiation and enhancer activation.\",\n      \"evidence\": \"Double conditional knockout with ChIP-seq, ATAC-seq, and RNA-seq\",\n      \"pmids\": [\"30988513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HNF4A–SMAD4 physical interaction not shown\", \"Paralog-specific contributions not separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked HNF4 to intestinal stem cell renewal through direct activation of fatty acid oxidation genes feeding the TCA cycle.\",\n      \"evidence\": \"Double conditional knockout with ChIP-seq, metabolic tracing, and organoid acetyl-CoA rescue\",\n      \"pmids\": [\"31759926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism connecting acetyl-CoA to stem cell maintenance not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed an additional MODY1 frameshift mutant acts by impaired transactivation without dominant negativity and perturbs foregut/hindgut identity.\",\n      \"evidence\": \"Patient-derived iPSC hepatopancreatic differentiation with expression profiling and localization\",\n      \"pmids\": [\"31195238\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic interpretation partly inferential\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Explained the FRTS R85W phenotype as a non-genomic mechanism: serine-phosphorylation-driven nuclear export causing cytosolic aggregation and cell stress.\",\n      \"evidence\": \"Drosophila nephrocyte expression with confocal/EM imaging, phosphosite mutagenesis, and genetic rescue\",\n      \"pmids\": [\"31875549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the responsible kinase not determined\", \"Conservation in human kidney cells not tested here\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed HNF4A upstream of ULK1-mediated autophagy in fatty liver via direct transcriptional activation, with miR-214-3p as an opposing regulator.\",\n      \"evidence\": \"ChIP, luciferase 3'UTR assay, LNA miRNA silencing, and autophagy flux assays in mouse liver\",\n      \"pmids\": [\"33078654\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct binding site on Ulk1 promoter not mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated therapeutic anti-fibrotic potential of restoring HNF4A and identified PON1 as a direct mediator.\",\n      \"evidence\": \"LNP HNF4A mRNA delivery in four fibrosis models, ChIP, and single-cell mechanistic dissection\",\n      \"pmids\": [\"34453962\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full anti-fibrotic target set beyond PON1 not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established HNF4 as an organizer of enhancer–promoter chromatin looping required for target gene expression in the intestine.\",\n      \"evidence\": \"H3K4me3 HiChIP-seq, ATAC-seq, ChIP-seq with conditional HNF4 knockout\",\n      \"pmids\": [\"33503426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HNF4 directly mediates loop formation or acts via cofactors unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Generalized HNF4's role to a conserved brush-border gene program across intestine, kidney, and yolk sac with loop reorganization.\",\n      \"evidence\": \"Multi-organ conditional knockout with ChIP-seq, HiChIP, RNA-seq, and transport assays\",\n      \"pmids\": [\"34001900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of gained looping at stress fiber loci not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined HNF4A as a lineage-determining factor that shapes the liver glucocorticoid receptor cistrome.\",\n      \"evidence\": \"GR and HNF4A ChIP-seq plus ATAC-seq in Hnf4a-null liver\",\n      \"pmids\": [\"35443180\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HNF4A–GR physical interaction not demonstrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed HNF4A control of the liver–alpha-cell axis via direct regulation of the glucagon receptor.\",\n      \"evidence\": \"Liver-specific conditional knockout with ChIP, glucagon challenge, and metabolic phenotyping\",\n      \"pmids\": [\"36464036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution to systemic glucose homeostasis vs local effects not fully separated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended HNF4A function to immune crosstalk, directly regulating butyrophilin and MHC-like genes controlling intraepithelial lymphocyte populations.\",\n      \"evidence\": \"IEC-specific conditional knockout, ChIP, and flow cytometry of IEL populations, with human conservation\",\n      \"pmids\": [\"35792863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which BTNL signals shape IEL selection not addressed here\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mapped tissue-dependent HNF4A target repertoires and distinguished the functional consequences of a T2D-associated variant from MODY1 loss-of-function alleles.\",\n      \"evidence\": \"ChIP-seq in pancreatic and hepatic cells with functional validation and variant comparison\",\n      \"pmids\": [\"38909044\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which rs1800961 alters DNA-binding affinity not directly measured\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Validated HNF4A as the dominant paralog for proximal tubule brush border identity in human kidney organoids.\",\n      \"evidence\": \"HNF4A/HNF4G knockout iPSC kidney organoids, CUT&RUN, CRISPRa, RNA-seq, and EM\",\n      \"pmids\": [\"37488681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why HNF4A but not HNF4G is required in this context not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed HNF4 paralogs activate mimetic-cell enhancers in thymic epithelium to recapitulate peripheral tissue gene programs for tolerance.\",\n      \"evidence\": \"Conditional Hnf4a/g knockout in TECs with scRNA-seq, ATAC-seq, ChIP, and CTCF analysis\",\n      \"pmids\": [\"37399024\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking HNF4-driven enhancers to CTCF redistribution unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established HNF4A as a basal repressor of acute-phase genes whose loss permits inflammatory derepression, defining a chromatin-gating role.\",\n      \"evidence\": \"Liver organoid HNF4A overexpression with chromatin accessibility and transcriptome profiling\",\n      \"pmids\": [\"38755249\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab organoid model\", \"Mechanism of chromatin retention at acute-phase loci not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How HNF4A switches between activator and repressor states at distinct loci, and how post-translational modifications and cofactor competition mechanistically direct enhancer looping, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking acetylation/phosphorylation status to genomic outcome\", \"Direct mediators of HNF4A-dependent chromatin looping not identified\", \"Structural basis of activator vs repressor switching unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 10, 11, 18, 20, 29, 31]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 2, 4, 8, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 8, 23]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 13, 26]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 5, 12, 21, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 19, 20, 27]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [26, 27, 28, 35]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NR2F2\", \"FOXA2\", \"GABP\", \"DDX3X\", \"SMAD4\", \"CREBBP\", \"NR0B2\", \"TCF7L2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}